Evidence-Based Medicine in Critical Care

Guyatt GH Sackett DL Sinclair JC . Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995;274: 1800–04.

Anson voyage around world. http://en.wikipedia.org/wiki/George_Anson%27s_voyage_around_the_world (accessed December 17th 2011).

James Lind. http://en.wikipedia.org/wiki/James_Lind (accessed December 17th 2011).

Shoemaker WC Appel PL Kram HB . Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988;94: 1176–86.

Heyland DK Cook DJ King D . Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med 1996;24: 517–24.

Kern JW Shoemaker WC . Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002;30: 1686–92.

Lees N Hamilton M Rhodes A . Clinical review: Goal-directed therapy in high risk surgical patients. Crit Care 2009;13: 231.

Otero RM Nguyen HB Huang DT . Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006;130: 1579–95.

Ziegler EJ Fisher CJ Jr. Sprung CL . Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991;324: 429–36.

McCloskey RV Straube RC Sanders C . Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Int Med 1994;121: 1–5.

van den Berghe G Wouters P Weekers F . Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345: 1359–67.

Wiener RS Wiener DC Larson RJ . Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300: 933–44.

Bernard GR Vincent JL Laterre PF . Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J of Med 2001;344: 699–709.

Annane D Bellissant E Bollaert PE . Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301: 2362–75.

Zandstra DF Petros AJ Taylor N . Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base. Crit Care 2010;14: 443.

Kopterides P Siempos II Armaganidis A . Prone positioning in hypoxemic respiratory failure: meta-analysis of randomized controlled trials. J Crit Care 2009;24: 89–100.

Dellinger RP Levy MM Carlet JM . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36: 296–327.

Finfer S . The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed. Crit Care Med 2010;38: 683–84.

Machado FR Freitas FG . Controversies of surviving sepsis campaign bundles: should we use them? Shock 2008;30 Suppl 1:34–40.

Brady AR Gibbs JS Greenhalgh RM . Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005;41: 602–09.

Peek GJ Mugford M Tiruvoipati R . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374: 1351–63.

Adhikari NK Burns KE Friedrich JO . Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007;334: 779.

Hillman K Chen J Cretikos M . Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet 2005;365: 2091–97.

Finfer S Bellomo R Boyce N . A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350: 2247–56.

Vincent JL . Logistics of large international trials: the good, the bad, and the ugly. Crit Care Med 2009;37: S75–S79.

Tonelli MR . The limits of evidence-based medicine. Resp Care 2001;46: 1435–40.

Bellomo R Warrillow SJ Reade MC . Why we should be wary of single-center trials. Crit Care Med 2009;37: 3114–19.

Borm GF Lemmers O Fransen J Donders R . The evidence provided by a single trial is less reliable than its statistical analysis suggests. J Clin Epidemiol 2009;62: 711–15.

Moore RA Derry S McQuay HJ . Fraud or flawed: adverse impact of fabricated or poor quality research. Anaesthesia 2010;65: 327–30.

Schulz KF Altman DG Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340: c332.

Hebert PC Wells G Blajchman MA . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340: 409–17.

The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342: 1301–08.

Lexchin J Bero LA Djulbegovic B Clark O . Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326: 1167–70.

Concato J Shah N Horwitz RI . Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342: 1887–92.

Trelle S Reichenbach S Wandel S . Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342: c7086.

Fergusson DA Hebert PC Mazer CD . A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358: 2319–31.

Smith GC Pell JP . Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. Int J Prosthodontics 2006;19: 126–28.